Form 4 Tracker
David P Hochman

Director, Chief Executive Officer and Chairperson · 3 filings · Latest: Mar 25, 2026

Orchestra BioMed Holdings, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
OBIO
David P HochmanDirector, Chief Executive Officer and ChairpersonMar 13, 2026
Purchase
$4.2910,000$42.9K1,086,467